Latest Breaking News On - Company or scisparc - Page 7 : comparemela.com

SciSparc Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Proprietary Psychedelic-Based Treatment

SciSparc Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Proprietary Psychedelic-Based Treatment
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Israel generalOz adlerJoseph tamClearmind medicine incScisparc ltdExchange commissionHebrew university of jerusalemCompany or scisparcClearmind medicineProfessor joseph tamHebrew universityCombination treatmentChief executiveTourette syndromeLooking statementsPrivate securities litigation reform act

SciSparc Announces Positive Results from its Weight Loss

The pre- clinical trial conducted using the combined treatment of SciSparc s proprietary CannAmide™ and Clearmind Medicine s MEAI molecule TEL AVIV,.

Israel generalJoseph tamOz adlerCompany or scisparcHebrew university of jerusalemScisparc ltdExchange commissionClearmind medicine incClearmind medicineProfessor joseph tamHebrew universityCombination treatmentChief executiveTourette syndromeLooking statementsPrivate securities litigation reform act

SciSparc Announces Positive Results for MitoCareX Bio with its Drug Discovery Platform

MitoCareX Bio has met its second milestone as part of its joint venture agreement with the Company TEL AVIV, Israel, Nov. 27, 2023 SciSparc Ltd. , a specialty clinical-stage.

Mitocarex bioMitocarex bio ltdCompany or scisparcScisparc ltdExchange commissionAlon silbermanInvestment agreementCarex bioSolute carrier familyTourette syndromeLooking statementsPrivate securities litigation reform actAnnual report

New Hope for Children: SciSparc s patented CBD- Enhanced Solution for Autism Spectrum Disorder -November 24, 2023 at 08:55 am EST

TEL AVIV, Israel, Nov. 24, 2023 SciSparc Ltd. , a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare disease of the central.

Oz adlerNational autism research centerCompany or scisparcSoroka medical centerGlobenewswire incScisparc ltdExchange commissionMedical centerAutism spectrum disorderChief executive officerAutism research centerTourette syndromeLooking statementsPrivate securities litigation reform actAnnual report

SciSparc (SPRC) has initiated a clinical trial using its proprietary therapy

SciSparc (SPRC) has initiated a clinical trial using its proprietary therapy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Oz adlerCompany or scisparcScisparc ltdSoroka medical centerNational autism research centerAutism spectrum disorderChief executive officer